• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于铁死亡相关基因的肾透明细胞癌预后模型及免疫浸润

Ferroptosis-Related Gene-Based Prognostic Model and Immune Infiltration in Clear Cell Renal Cell Carcinoma.

作者信息

Zhao Guo-Jiang, Wu Zonglong, Ge Liyuan, Yang Feilong, Hong Kai, Zhang Shudong, Ma Lulin

机构信息

Department of Urology, Peking University Third Hospital, Beijing, China.

出版信息

Front Genet. 2021 Jun 9;12:650416. doi: 10.3389/fgene.2021.650416. eCollection 2021.

DOI:10.3389/fgene.2021.650416
PMID:34178024
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8220217/
Abstract

Clear cell renal cell carcinoma (ccRCC) is one of the most common tumors in the urinary system. Ferroptosis plays a vital role in ccRCC development and progression. We did an update of ferroptosis-related multigene expression signature for individualized prognosis prediction in patients with ccRCC. Differentially expressed ferroptosis-related genes in ccRCC and normal samples were screened using The Cancer Genome Atlas. Univariate and multivariate Cox regression analyses and machine learning methods were employed to identify optimal prognosis-related genes. , , , , , , and were selected to establish a prognostic risk score model. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses revealed that these genes were mainly enriched in immune-related pathways; single-sample Gene Set Enrichment Analysis revealed several immune cells potentially related to ferroptosis. Kaplan-Meier survival analysis demonstrated that patients with high-risk scores had significantly poor overall survival (log-rank = 7.815 × 10). The ferroptosis signature was identified as an independent prognostic factor. Finally, a prognostic nomogram, including the ferroptosis signature, age, histological grade, and stage status, was constructed. Analysis of The Cancer Genome Atlas-based calibration plots, C-index, and decision curve indicated the excellent predictive performance of the nomogram. The ferroptosis-related seven-gene risk score model is useful as a prognostic biomarker and suggests therapeutic targets for ccRCC. The prognostic nomogram may assist in individualized survival prediction and improve treatment strategies.

摘要

透明细胞肾细胞癌(ccRCC)是泌尿系统中最常见的肿瘤之一。铁死亡在ccRCC的发生发展中起着至关重要的作用。我们对与铁死亡相关的多基因表达特征进行了更新,以用于ccRCC患者的个体化预后预测。利用癌症基因组图谱筛选ccRCC和正常样本中差异表达的铁死亡相关基因。采用单因素和多因素Cox回归分析以及机器学习方法来鉴定最佳的预后相关基因。选择了[具体基因名称未给出]来建立预后风险评分模型。基因本体论和京都基因与基因组百科全书通路分析表明,这些基因主要富集于免疫相关通路;单样本基因集富集分析揭示了几种可能与铁死亡相关的免疫细胞。Kaplan-Meier生存分析表明,高风险评分的患者总体生存率显著较差(对数秩检验 = 7.815×10)。铁死亡特征被确定为一个独立的预后因素。最后,构建了一个预后列线图,包括铁死亡特征、年龄、组织学分级和分期状态。基于癌症基因组图谱的校准图、C指数和决策曲线分析表明列线图具有出色的预测性能。与铁死亡相关的七基因风险评分模型作为一种预后生物标志物很有用,并为ccRCC提示了治疗靶点。预后列线图可能有助于个体化生存预测并改善治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a00f/8220217/b457e78eec23/fgene-12-650416-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a00f/8220217/822d4a54e659/fgene-12-650416-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a00f/8220217/a3bc45589ff3/fgene-12-650416-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a00f/8220217/9ecd3601ed43/fgene-12-650416-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a00f/8220217/349ce3efb0cf/fgene-12-650416-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a00f/8220217/4a9ff5a7359f/fgene-12-650416-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a00f/8220217/b457e78eec23/fgene-12-650416-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a00f/8220217/822d4a54e659/fgene-12-650416-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a00f/8220217/a3bc45589ff3/fgene-12-650416-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a00f/8220217/9ecd3601ed43/fgene-12-650416-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a00f/8220217/349ce3efb0cf/fgene-12-650416-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a00f/8220217/4a9ff5a7359f/fgene-12-650416-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a00f/8220217/b457e78eec23/fgene-12-650416-g006.jpg

相似文献

1
Ferroptosis-Related Gene-Based Prognostic Model and Immune Infiltration in Clear Cell Renal Cell Carcinoma.基于铁死亡相关基因的肾透明细胞癌预后模型及免疫浸润
Front Genet. 2021 Jun 9;12:650416. doi: 10.3389/fgene.2021.650416. eCollection 2021.
2
A novel ferroptosis-related 12-gene signature predicts clinical prognosis and reveals immune relevancy in clear cell renal cell carcinoma.一种新型铁死亡相关的 12 基因标志物可预测透明细胞肾细胞癌的临床预后并揭示其免疫相关性。
BMC Cancer. 2021 Jul 19;21(1):831. doi: 10.1186/s12885-021-08559-0.
3
Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.基于铁死亡相关基因特征预测透明细胞肾细胞癌患者的总生存期。
World J Surg Oncol. 2022 Apr 14;20(1):120. doi: 10.1186/s12957-022-02555-9.
4
Ferroptosis-Related Gene Signature Accurately Predicts Survival Outcomes in Patients With Clear-Cell Renal Cell Carcinoma.铁死亡相关基因特征可准确预测透明细胞肾细胞癌患者的生存结局。
Front Oncol. 2021 Apr 30;11:649347. doi: 10.3389/fonc.2021.649347. eCollection 2021.
5
Accurate prognostic prediction for patients with clear cell renal cell carcinoma using a ferroptosis-related long non-coding RNA risk model.基于铁死亡相关长非编码 RNA 风险模型对透明细胞肾细胞癌患者进行准确预后预测。
Cancer Biomark. 2023;37(2):95-107. doi: 10.3233/CBM-210445.
6
Construction of A Novel Ferroptosis-related Prognostic Risk Signature for Survival Prediction in Clear Cell Renal Cell Carcinoma Patients.构建新型铁死亡相关预后风险模型预测透明细胞肾细胞癌患者的生存情况。
Urol J. 2022 May 22;19(4):289-299. doi: 10.22037/uj.v19i.6999.
7
A new survival model based on ferroptosis-related genes for prognostic prediction in clear cell renal cell carcinoma.基于铁死亡相关基因的新型生存模型用于预测透明细胞肾细胞癌的预后。
Aging (Albany NY). 2020 Jul 20;12(14):14933-14948. doi: 10.18632/aging.103553.
8
A Novel Prognostic Model Based on Ferroptosis-Related Gene Signature for Bladder Cancer.一种基于铁死亡相关基因特征的膀胱癌新型预后模型。
Front Oncol. 2021 Aug 6;11:686044. doi: 10.3389/fonc.2021.686044. eCollection 2021.
9
Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.鉴定铁死亡相关基因特征在乳腺癌患者中的预后价值。
BMC Cancer. 2021 May 31;21(1):645. doi: 10.1186/s12885-021-08341-2.
10
Identification and Validation of a Ferroptosis-Related Long Non-Coding RNA (FRlncRNA) Signature to Predict Survival Outcomes and the Immune Microenvironment in Patients With Clear Cell Renal Cell Carcinoma.一种用于预测透明细胞肾细胞癌患者生存结局和免疫微环境的铁死亡相关长链非编码RNA(FRlncRNA)特征的鉴定与验证
Front Genet. 2022 Mar 8;13:787884. doi: 10.3389/fgene.2022.787884. eCollection 2022.

引用本文的文献

1
Ferroptosis-associated genes and compounds in renal cell carcinoma.肾细胞癌中与铁死亡相关的基因和化合物。
Front Immunol. 2024 Sep 27;15:1473203. doi: 10.3389/fimmu.2024.1473203. eCollection 2024.
2
A new perspective: deciphering the aberrance and clinical implication of disulfidptosis signatures in clear cell renal cell carcinoma.一个新视角:解析在肾透明细胞癌中二硫键错配特征的异常和临床意义。
Aging (Albany NY). 2024 Jun 10;16(11):10033-10062. doi: 10.18632/aging.205916.
3
Development and implementation of a prognostic model for clear cell renal cell carcinoma based on heterogeneous TLR4 expression.

本文引用的文献

1
SUV39H1 deficiency suppresses clear cell renal cell carcinoma growth by inducing ferroptosis.SUV39H1基因缺失通过诱导铁死亡抑制肾透明细胞癌生长。
Acta Pharm Sin B. 2021 Feb;11(2):406-419. doi: 10.1016/j.apsb.2020.09.015. Epub 2020 Sep 30.
2
The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.纳米颗粒在癌症免疫治疗中的应用:靶向肿瘤微环境。
Bioact Mater. 2020 Dec 26;6(7):1973-1987. doi: 10.1016/j.bioactmat.2020.12.010. eCollection 2021 Jul.
3
Low expression of ferritinophagy-related NCOA4 gene in relation to unfavorable outcome and defective immune cells infiltration in clear cell renal carcinoma.
基于异质性TLR4表达的透明细胞肾细胞癌预后模型的开发与应用
Heliyon. 2024 Feb 12;10(4):e25571. doi: 10.1016/j.heliyon.2024.e25571. eCollection 2024 Feb 29.
4
Identification and validation of a ferroptosis-related signature for prediction of the prognosis and tumor microenvironment in patients with chromophobe renal cell carcinoma.鉴定和验证与铁死亡相关的标志物,用于预测嗜铬细胞瘤肾细胞癌患者的预后和肿瘤微环境。
BMC Cancer. 2023 Nov 8;23(1):1079. doi: 10.1186/s12885-023-11589-5.
5
Bulk RNA-seq and scRNA-seq reveal SLC7A11, a key regulatory molecule of ferroptosis, is a prognostic-related biomarker and highly related to the immune system in lung adenocarcinoma. bulk RNA-seq 和 scRNA-seq 揭示 SLC7A11 是铁死亡的关键调节分子,是肺腺癌中与预后相关的生物标志物,与免疫系统密切相关。
Medicine (Baltimore). 2023 Sep 15;102(37):e34876. doi: 10.1097/MD.0000000000034876.
6
Multi-omics identification of an immunogenic cell death-related signature for clear cell renal cell carcinoma in the context of 3P medicine and based on a 101-combination machine learning computational framework.在3P医学背景下,基于101组合机器学习计算框架对透明细胞肾细胞癌免疫原性细胞死亡相关特征进行多组学鉴定。
EPMA J. 2023 May 31;14(2):275-305. doi: 10.1007/s13167-023-00327-3. eCollection 2023 Jun.
7
Single-Cell RNA-Seq Analysis Reveals Ferroptosis in the Tumor Microenvironment of Clear Cell Renal Cell Carcinoma.单细胞 RNA-Seq 分析揭示了透明细胞肾细胞癌肿瘤微环境中的铁死亡。
Int J Mol Sci. 2023 May 22;24(10):9092. doi: 10.3390/ijms24109092.
8
A Novel 7-Methylguanosine (m7G)-Related Gene Signature for Overall Survival Prediction in Patient with Clear Cell Renal Cell Carcinoma.一种用于预测透明细胞肾细胞癌患者总生存期的新型7-甲基鸟苷(m7G)相关基因特征
J Oncol. 2023 Apr 8;2023:9645038. doi: 10.1155/2023/9645038. eCollection 2023.
9
Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.铁死亡和免疫相关生物标志物的综合分析及其与骨肉瘤相关的机制。
Sci Rep. 2023 Apr 8;13(1):5770. doi: 10.1038/s41598-023-33009-1.
10
Identification and Validation of a Novel Ferroptotic Prognostic Genes-Based Signature of Clear Cell Renal Cell Carcinoma.基于新型铁死亡预后基因的肾透明细胞癌特征的鉴定与验证
Cancers (Basel). 2022 Sep 27;14(19):4690. doi: 10.3390/cancers14194690.
铁蛋白自噬相关基因 NCOA4 低表达与肾透明细胞癌不良预后及免疫细胞浸润缺陷有关。
BMC Cancer. 2021 Jan 5;21(1):18. doi: 10.1186/s12885-020-07726-z.
4
CD44 as a tumor biomarker and therapeutic target.CD44作为一种肿瘤生物标志物和治疗靶点。
Exp Hematol Oncol. 2020 Dec 10;9(1):36. doi: 10.1186/s40164-020-00192-0.
5
SLC7A11/xCT in cancer: biological functions and therapeutic implications.癌症中的溶质载体家族7成员11/胱氨酸-谷氨酸反向转运体:生物学功能及治疗意义
Am J Cancer Res. 2020 Oct 1;10(10):3106-3126. eCollection 2020.
6
Ferroptosis in Cancer Treatment: Another Way to Rome.癌症治疗中的铁死亡:通往罗马的另一条路。
Front Oncol. 2020 Sep 25;10:571127. doi: 10.3389/fonc.2020.571127. eCollection 2020.
7
Long non-coding RNA LINC01234 regulates proliferation, migration and invasion via HIF-2α pathways in clear cell renal cell carcinoma cells.长链非编码RNA LINC01234通过缺氧诱导因子-2α途径调控肾透明细胞癌细胞的增殖、迁移和侵袭。
PeerJ. 2020 Oct 14;8:e10149. doi: 10.7717/peerj.10149. eCollection 2020.
8
Ferroptosis: An emerging approach for targeting cancer stem cells and drug resistance.铁死亡:一种针对肿瘤干细胞和耐药性的新方法。
Crit Rev Oncol Hematol. 2020 Nov;155:103095. doi: 10.1016/j.critrevonc.2020.103095. Epub 2020 Sep 5.
9
Ferroptosis: machinery and regulation.铁死亡:机制与调控。
Autophagy. 2021 Sep;17(9):2054-2081. doi: 10.1080/15548627.2020.1810918. Epub 2020 Aug 26.
10
ACC1 determines memory potential of individual CD4 T cells by regulating de novo fatty acid biosynthesis.ACC1 通过调节从头脂肪酸生物合成来决定个体 CD4 T 细胞的记忆潜能。
Nat Metab. 2019 Feb;1(2):261-275. doi: 10.1038/s42255-018-0025-4. Epub 2019 Jan 14.